Portal hypertension secondary to myelofibrosis: A study of three cases

American Journal of Gastroenterology

Volumn 100, Issue 10, 2005, Pages 2355-2358

  Alvarez Larrán, Alberto ^a   Abraldes, Juan G ^b   Cervantes, Francisco ^a   Hernández Guerra, Manuel ^b   Vizzutti, Francesco ^c   Miquel, Rosa ^d   Gilabert, Rosa ^d   Giusti, Massimo ^e   Garcia Pagan, Juan Carlos ^b,f   Bosch, Jaime ^b  

^a Arcispedale Santa Maria Nuova   (Italy)

^b Liver Unit   (Spain)

^c Dipto Ad Attivita Integrata Specialita Medico Chirurgiche UO Malattie Epatiche Ed Intestinali   (Italy)

^d UNIVERSITY OF BARCELONA   (Spain)

^e Ospedale Civile di Pistoia   (Italy)

^f HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; POLITEF; PROPRANOLOL;

ADULT; AGED; ARTICLE; ASCITES; CASE REPORT; COLOR ULTRASOUND FLOWMETRY; ESOPHAGUS VARICES BLEEDING; HEMODYNAMIC MONITORING; HUMAN; IDIOPATHIC DISEASE; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER SINUSOID; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; PARACENTESIS; PORTAL HYPERTENSION; PORTAL VEIN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SPLENIC VEIN; STENT; VARICOSIS; VEIN CATHETERIZATION; VENOUS PRESSURE; ECHOGRAPHY; LIVER CIRCULATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR RESISTANCE;

AGED; HUMANS; HYPERTENSION, PORTAL; LIVER CIRCULATION; MALE; MIDDLE AGED; MYELOFIBROSIS; PORTAL SYSTEM; VASCULAR RESISTANCE;

EID: 27744505784     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.50374.x     Document Type: Article

References (24)

1. Barosi G. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 1999 17 : 2954 70.
2. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000 342 : 1255 65.
3. Pereira A Bruguera M Cervantes F, et al. Liver involvement at diagnosis of primary myelofibrosis: A clinicopathological study of twenty-two cases. Eur J Haematol 1988 40 : 355 61.
4. Ligumski M Polliack A Benbassat J. Nature and incidence of liver involvement in agnogenic myeloid metaplasia. Scand J Haematol 1978 21 : 81 93.
5. Silverstein MN Wollaeger EE Baggenstoss AH. Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia. Arch Intern Med 1973 131 : 532 7.
6. Escartin Marin P Arenas Mirave JI Boixeda D, et al. Hemodynamic study of the portal system in 6 cases of myeloid metaplasia. Rev Clin Esp 1977 145 : 271 3.
7. Roux D Merlio JP Quinton A, et al. Agnogenic myeloid metaplasia, portal hypertension, and sinusoidal abnormalities. Gastroenterology 1987 92 : 1067 72.
8. Dubois A Dauzat M Pignodel C, et al. Portal hypertension in lymphoproliferative and myeloproliferative disorders: Hemodynamic and histological correlations. Hepatology 1993 17 : 246 50.
9. Lee WC Lin HC Tsay SH, et al. Esophageal variceal ligation for esophageal variceal hemorrhage in a patient with portal and primary pulmonary hypertension complicating myelofibrosis. Dig Dis Sci 2001 46 : 915 9.
10. Tefferi A Mesa RA Nagorney DM, et al. Splenectomy in myelofibrosis with myeloid metaplasia: A single-institution experience with 223 patients. Blood 2000 95 : 2226 33.
11. Benbassat J Penchas S Ligumski M. Splenectomy in patients with agnogenic myeloid metaplasia: An analysis of 321 published cases. Br J Haematol 1979 42 : 207 14.
12. Lopez-Guillermo A Cervantes F Bruguera M, et al. Liver dysfunction following splenectomy in idiopathic myelofibrosis: A study of 10 patients. Acta Haematol 1991 85 : 184 8.
13. Barosi G Ambrosetti A Buratti A, et al. Splenectomy for patients with myelofibrosis with myeloid metaplasia: Pretreatment variables and outcome prediction. Leukemia 1993 7 : 200 6.
14. Tefferi A Barrett SM Silverstein MN, et al. Outcome of portal-systemic shunt surgery for portal hypertension associated with intrahepatic obstruction in patients with agnogenic myeloid metaplasia. Am J Hematol 1994 46 : 325 8.
15. Rosado B Kamath PS. Transjugular intrahepatic portosystemic shunts: An update. Liver Transpl 2003 9 : 207 17.
16. Perello A Garcia-Pagan JC Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002 35 : 132 9.
17. Angermayr B Cejna M Schoder M, et al. Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis. Blood 2002 99 : 4246 7.
18. Tanaka N Yamakado K Kihira H, et al. Transjugular intrahepatic portosystemic shunt for intractable esophageal-gastric variceal hemorrhage in a patient with idiopathic myelofibrosis. Cardiovasc Intervent Radiol 2000 23 : 491 2.
19. Wiest R Strauch U Wagner H, et al. A patient with myelofibrosis complicated by refractory ascites and portal hypertension: To tips or not to tips? A case report with discussion of the mechanism of ascites formation. Scand J Gastroenterol 2004 39 : 389 94.
20. Belohlavek J Schwarz J Jirasek A, et al. Idiopathic myelofibrosis complicated by portal hypertension treated with a transjugular intrahepatic portosystemic shunt (TIPS). Wien Klin Wochenschr 2001 113 : 208 11.
21. Sikuler E Kravetz D Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985 248 : G618 25.
22. Wanless IR Peterson P Das A, et al. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsy. Hepatology 1990 12 : 1166 74.
23. Bellis L Moitinho E Abraldes JG, et al. Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Gut 2003 52 : 130 3.
24. Casado M Bosch J Garcia-Pagan JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings. Gastroenterology 1998 114 : 1296 303.